Pneumococcal Vaccine (Prevnar, PCV13)
Pneumococcal vaccine (PCV13), also called Prevnar, protects against the 13 most common types of pneumonia.
- Children should get 4 doses of Prevnar, at 2, 4, 6 and 12-15 months
- It is recommended for all children 23 months of age and younger.
- All children under the age of 2, who attend child care in Minnesota,
must get the pneumococcal vaccine, or file appropriate exemptions.
- The vaccine is particularly recommended for high risk children, those with sickle cell disease, no or poorly functioning spleen; human immunodeficiency virus (HIV) infection or other illnesses that weaken the immune system; have a cerebrospinal fluid leak or cochlear implants.
- Children 2 to 5 years old who are at high risk for pneumococcal meningitis, pneumonia, or blood infection should get the Pneumococcal Polysaccharide Vaccine (PPSV).
- Pneumococcal Conjugate
Vaccine (PCV13): What You Need to Know
CDC's vaccine information statement (VIS) in English and other languages. Attention: Non-MDH link
Vaccine (Pneumococcal Conjugate)
Questions and answers for parents, health care professionals, and people considering immunization from the CDC. Attention: Non-MDH link
Immunization Action Coalition page including journal articles, recommendations, case histories, photos, and vaccine shortage information. Attention: Non-MDH link